Shai S. Erlich
Director Técnico/Científico/I+D en Quark Pharmaceuticals, Inc. .
Perfil
Shai S.
Erlich is currently the President-US Operations & Chief Medical Officer at Quark Pharmaceuticals, Inc. He started this position in 2010.
Prior to his current role, he has a background in education, having obtained a graduate degree from Tel-Aviv University, an undergraduate degree from Ben-Gurion University of the Negev, and a doctorate degree from Icahn School of Medicine at Mount Sinai.
Cargos activos de Shai S. Erlich
Empresas | Cargo | Inicio |
---|---|---|
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Director Técnico/Científico/I+D | 27/09/2010 |
Formación de Shai S. Erlich.
Ben-Gurion University of the Negev | Undergraduate Degree |
Tel-Aviv University | Graduate Degree |
Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Shai S. Erlich